Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NCEH1 | Q6PIU2 | 6/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | PGR | P06401 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | FAAH | O00519 | 2/20 | 0.39 |
| ▸ | CES2 | O00748 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19712933 | 0.94 | FAAH (0.40) | NCEH1FAAHCES2CYP1A2CYP2A6 | |
| SCHEMBL19712917 | 0.89 | NCEH1 (0.53) | NCEH1ALDH1A1PGRGAAPTGS1 | |
| SCHEMBL19712900 | 0.86 | NCEH1 (0.44) | NCEH1ALDH1A1PGRGAAPTGS1 | |
| SCHEMBL19712941 | 0.86 | NCEH1 (0.44) | NCEH1ALDH1A1PGRGAAPTGS1 | |
| SCHEMBL19712944 | 0.86 | NCEH1 (0.50) | NCEH1MAPTNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL19712898 | 0.84 | NCEH1 (0.44) | NCEH1FAAH | |
| SCHEMBL19712896 | 0.83 | NCEH1 (0.45) | NCEH1NPC1RAB9A | |
| SCHEMBL29549014 | 0.82 | NCEH1 (0.41) | NCEH1ALDH1A1PGRGAAPTGS1 | |
| SCHEMBL19712899 | 0.81 | NCEH1 (0.42) | NCEH1ALDH1A1PGRGAAPTGS1 | |
| SCHEMBL29622104 | 0.81 | NCEH1 (0.41) | NCEH1ALDH1A1PGRGAAPTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11267943-B2 | Film structure containing a photopolymer layer for holographic exposure and a coating layer of high resistance | COVESTRO DEUTSCHLAND AG (DE) | 2022-03-08 | — | — | US | disclosed |
| US-20210292505-A1 | FILM STRUCTURE CONTAINING A PHOTOPOLYMER LAYER FOR HOLOGRAPHIC EXPOSURE AND A COATING LAYER OF HIGH RESISTANCE | COVESTRO DEUTSCHLAND AG (DE) | 2021-09-23 | — | — | US | disclosed |
| US-10241402-B2 | Naphthyl acrylates as writing monomers for photopolymers | COVESTRO DEUTSCHLAND AG (DE) | 2019-03-26 | — | — | US | disclosed |
| US-20170363957-A1 | NAPHTHYL ACRYLATES AS WRITING MONOMERS FOR PHOTOPOLYMERS | COVESTRO DEUTSCHLAND AG (DE) | 2017-12-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170363957-A1 | NAPHTHYL ACRYLATES AS WRITING MONOMERS FOR PHOTOPOLYMERS | NEFM, ACR, DIAPH1 | NCEH1 4259/4885ALDH1A1 1558/4885PGR 1480/4885 |
| US-10241402-B2 | Naphthyl acrylates as writing monomers for photopolymers | NEFM, ACR, DIAPH1 | NCEH1 4259/4885ALDH1A1 1558/4885PGR 1480/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.